US Broker Ratings

XOMA Royalty Corporation (XOMA) Stock Analysis: Exploring a Potential 105% Upside in Biotechnology

XOMA Royalty Corporation (XOMA), a name synonymous with innovation in the biotechnology sector, presents an intriguing opportunity for investors. As a royalty aggregator, XOMA focuses on acquiring economic rights to..

Varex Imaging Corporation (VREX): Exploring a 50.98% Potential Upside in the Medical Devices Space

Varex Imaging Corporation (NASDAQ: VREX) represents an intriguing opportunity within the healthcare sector, specifically the medical devices industry. With a market capitalization of $489.53 million, this Salt Lake City-based company..

AMTD Digital Inc. (HKD) Stock Analysis: Navigating Challenges with a 15.52% Return on Equity

AMTD Digital Inc. (NASDAQ: HKD) operates within the ever-evolving technology sector, specifically in the software application industry. Despite its roots in France, AMTD Digital serves a global clientele spread across..

Abeona Therapeutics Inc. (ABEO) Investor Outlook: Exploring a Potential 278.93% Upside

Abeona Therapeutics Inc. (NASDAQ: ABEO), a promising player in the biotechnology sector, is capturing the attention of investors with its potential for significant upside. As a clinical-stage biopharmaceutical company, Abeona..

Alpha Teknova, Inc. (TKNO) Stock Analysis: Strong Buy Ratings and an 80% Potential Upside

For investors with a keen eye on the healthcare sector, Alpha Teknova, Inc. (NASDAQ: TKNO) presents a compelling opportunity. Operating in the niche industry of drug manufacturers specializing in specialty..

Porch Group, Inc. (PRCH) Stock Analysis: A Tech Sector Standout with 31% Potential Upside

Porch Group, Inc. (PRCH), a dynamic player in the technology sector, has caught the eye of investors with its intriguing growth potential and strategic positioning in the software application industry...

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring a 193% Potential Upside in Biotech Innovation

For investors keen on the biotechnology sector, Entrada Therapeutics, Inc. (NASDAQ: TRDA) presents an intriguing prospect with a staggering 193% potential upside, according to analysts’ ratings. Despite recent challenges, this..

Chevron Corporation (CVX) Investor Outlook: Assessing a 9.32% Upside Potential Amid Market Dynamics

Chevron Corporation (CVX), a titan in the integrated oil and gas industry, continues to command attention with its vast market capitalization of $313.45 billion. As one of the stalwarts in..

NANO-X IMAGING LTD (NNOX) Stock Analysis: Potential Upside of 93% Amidst Growing Healthcare Innovation

Nano-X Imaging Ltd. (NASDAQ: NNOX) is carving a niche in the healthcare sector with its cutting-edge medical imaging solutions. Headquartered in Petah Tikva, Israel, Nano-X is on a mission to..

Alumis Inc. (ALMS) Stock Analysis: Exploring a 323% Potential Upside in Biotechnology

Alumis Inc. (NASDAQ: ALMS), a burgeoning name in the biotechnology sector, continues to draw investor attention with its impressive potential upside of 323.16%. As a clinical-stage biopharmaceutical company, Alumis is..

Aura Biosciences, Inc. (AURA) Stock Analysis: Unveiling a 268% Potential Upside in the Biotech Sector

Aura Biosciences, Inc. (NASDAQ: AURA) presents a compelling opportunity for investors looking to capitalize on the burgeoning biotechnology sector. With a market capitalization of $357.81 million, Aura Biosciences is a..

Heron Therapeutics, Inc. (HRTX) Stock Analysis: Unlocking a Potential 299% Upside

Heron Therapeutics, Inc. (NASDAQ: HRTX) is making waves in the biotechnology sector, offering promising opportunities for investors with a keen eye on future growth. With a market capitalization of $218.14..

Compass Therapeutics, Inc. (CMPX) Stock Analysis: Unpacking a 210% Potential Upside in the Biotech Space

Compass Therapeutics, Inc. (CMPX) is making waves in the biotechnology sector with its promising portfolio of antibody-based therapeutics targeting cancer treatment. As a clinical-stage biopharmaceutical company based in Boston, Massachusetts,..

Outset Medical, Inc. (OM) Investor Outlook: Unveiling a 71% Potential Upside with Innovative Hemodialysis Solutions

Outset Medical, Inc. (NASDAQ: OM) is making waves in the healthcare sector with its innovative approach to hemodialysis. Headquartered in San Jose, California, this medical technology company is redefining kidney..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A 470% Upside Potential Amid Clinical Trials

Investors with an eye on the biotechnology sector may find Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) an intriguing opportunity, especially given its impressive potential upside of 470.84%. While the company’s..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: A High-Stakes Bet in Biotechnology with 24.9% Potential Upside

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), a noteworthy player in the biotechnology industry, has captured investor attention with its robust revenue growth and a promising pipeline of innovative therapies. Headquartered in..

Olema Pharmaceuticals (OLMA) Stock Analysis: A 197.62% Potential Upside in the Biotech Sector

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) is capturing the attention of savvy investors in the biotech space with its noteworthy potential upside of 197.62%. The company, which operates in the healthcare..

Benitec Biopharma Inc. (BNTC) Stock Analysis: A Look at Its 57% Potential Upside

Investors in the biotechnology sector are no strangers to the high stakes and potential high rewards that come with investing in innovative companies. Benitec Biopharma Inc. (NASDAQ: BNTC), headquartered in..

aTyr Pharma, Inc. (ATYR) Stock Analysis: Unpacking the 313.95% Potential Upside

aTyr Pharma, Inc. (ATYR) stands as a compelling opportunity within the biotechnology sector, drawing attention with its significant potential upside of 313.95%. As a clinical-stage company, aTyr Pharma is on..

Absci Corporation (ABSI) Stock Analysis: Exploring an 89.66% Potential Upside in Biotech Innovation

Absci Corporation (NASDAQ: ABSI) is capturing the attention of investors with its promising technological advancements in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $640.7..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds